Curis
CRIS
#11190
Rank
NZ$2.9 M
Marketcap
NZ$1.20
Share price
-5.38%
Change (1 day)
-57.49%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$24.95

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$25.34. In 2025 the company made an earnings per share (EPS) of NZ-$42.43 an increase over its 2024 EPS that were of NZ-$250.54.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$24.95-41.2%
2025NZ-$42.43-83.07%
2024NZ-$250.54-22.15%
2023NZ-$321.81-26.17%
2022NZ-$435.8522.3%
2021NZ-$356.38-25.37%
2020NZ-$477.55-30.93%
2019NZ-$691.38-2.02%
2018NZ-$705.63
2016NZ-$1,604-10%
2015NZ-$1,782138.1%
2014NZ-$748.4040%
2013NZ-$534.57-25%
2012NZ-$712.7666.67%
2011NZ-$427.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.35-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.09-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.64-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.88-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.75-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.67-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.13-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA